Cargando…
A Comparative Investment Analysis of Batch Versus Continuous Pharmaceutical Manufacturing Technologies
PURPOSE: This study examines the risks and economics associated with investing in continuous (CM) versus conventional batch manufacturing for production of oral solid dosage pharmaceutical (OSD) products in the USA and abroad. METHODS: A stochastic net present value (NPV) simulation of brand and gen...
Autor principal: | Rossi, Clifford V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802271/ https://www.ncbi.nlm.nih.gov/pubmed/35126780 http://dx.doi.org/10.1007/s12247-021-09612-y |
Ejemplares similares
-
Batch versus continuous blending of binary and ternary pharmaceutical powder mixtures
por: Jaspers, Maarten, et al.
Publicado: (2022) -
Continuous Pharmaceutical Manufacturing
por: Korhonen, Ossi
Publicado: (2020) -
Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
por: Anyakora, Chimezie, et al.
Publicado: (2017) -
Perspectives on the flexibility analysis for continuous pharmaceutical manufacturing processes
por: Yang, Wenhui, et al.
Publicado: (2022) -
3D printing and continuous flow chemistry technology to advance pharmaceutical manufacturing in developing countries
por: Sagandira, Cloudius R., et al.
Publicado: (2020)